Our results highlight a shared neuroinflammatory signature across Alzheimer’s disease (AD), Parkinson’s disease (PD), and Huntington’s disease (HD), characterized by the dysregulation of hub genes such as MMP9, S100A8, S100A9, CCL2, and LCN2. This evidence concerns the gene S100A8 and juvenile Huntington disease.